PET/CT in the management of haematological malignancies

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

PET/CT in the management of haematological malignancies. / Hutchings, Martin; Specht, Lena; Hutchings, Martin; Specht, Lena.

I: European Journal of Haematology. Supplementum, Bind 80, Nr. 5, 01.05.2008, s. 369-80.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Hutchings, M, Specht, L, Hutchings, M & Specht, L 2008, 'PET/CT in the management of haematological malignancies', European Journal of Haematology. Supplementum, bind 80, nr. 5, s. 369-80. https://doi.org/10.1111/j.1600-0609.2008.01051.x, https://doi.org/10.1111/j.1600-0609.2008.01051.x

APA

Hutchings, M., Specht, L., Hutchings, M., & Specht, L. (2008). PET/CT in the management of haematological malignancies. European Journal of Haematology. Supplementum, 80(5), 369-80. https://doi.org/10.1111/j.1600-0609.2008.01051.x, https://doi.org/10.1111/j.1600-0609.2008.01051.x

Vancouver

Hutchings M, Specht L, Hutchings M, Specht L. PET/CT in the management of haematological malignancies. European Journal of Haematology. Supplementum. 2008 maj 1;80(5):369-80. https://doi.org/10.1111/j.1600-0609.2008.01051.x, https://doi.org/10.1111/j.1600-0609.2008.01051.x

Author

Hutchings, Martin ; Specht, Lena ; Hutchings, Martin ; Specht, Lena. / PET/CT in the management of haematological malignancies. I: European Journal of Haematology. Supplementum. 2008 ; Bind 80, Nr. 5. s. 369-80.

Bibtex

@article{e4cbbcd04c7b11df928f000ea68e967b,
title = "PET/CT in the management of haematological malignancies",
abstract = "Positron emission tomography (PET)/computerised tomography (CT) has proved useful in a number of haematological malignancies, particularly in Hodgkin lymphoma (HL) and aggressive non-Hodgkin lymphomas (NHL). It is recommended in the staging of HL and aggressive NHL, it has been shown to be prognostically important early during treatment, and it has been incorporated in the response criteria. However, treatment modification based on early scans is still experimental, and routine use in follow up cannot be recommended. The use of PET/CT in other lymphoma types and other haematological malignancies is still under evaluation.",
author = "Martin Hutchings and Lena Specht and Martin Hutchings and Lena Specht",
note = "Keywords: Follow-Up Studies; Hematologic Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Salvage Therapy; Tomography, X-Ray Computed",
year = "2008",
month = "5",
day = "1",
doi = "10.1111/j.1600-0609.2008.01051.x",
language = "English",
volume = "80",
pages = "369--80",
journal = "European Journal of Haematology. Supplementum",
issn = "0902-4506",
publisher = "Wiley-Blackwell",
number = "5",

}

RIS

TY - JOUR

T1 - PET/CT in the management of haematological malignancies

AU - Hutchings, Martin

AU - Specht, Lena

AU - Hutchings, Martin

AU - Specht, Lena

N1 - Keywords: Follow-Up Studies; Hematologic Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Salvage Therapy; Tomography, X-Ray Computed

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Positron emission tomography (PET)/computerised tomography (CT) has proved useful in a number of haematological malignancies, particularly in Hodgkin lymphoma (HL) and aggressive non-Hodgkin lymphomas (NHL). It is recommended in the staging of HL and aggressive NHL, it has been shown to be prognostically important early during treatment, and it has been incorporated in the response criteria. However, treatment modification based on early scans is still experimental, and routine use in follow up cannot be recommended. The use of PET/CT in other lymphoma types and other haematological malignancies is still under evaluation.

AB - Positron emission tomography (PET)/computerised tomography (CT) has proved useful in a number of haematological malignancies, particularly in Hodgkin lymphoma (HL) and aggressive non-Hodgkin lymphomas (NHL). It is recommended in the staging of HL and aggressive NHL, it has been shown to be prognostically important early during treatment, and it has been incorporated in the response criteria. However, treatment modification based on early scans is still experimental, and routine use in follow up cannot be recommended. The use of PET/CT in other lymphoma types and other haematological malignancies is still under evaluation.

U2 - 10.1111/j.1600-0609.2008.01051.x

DO - 10.1111/j.1600-0609.2008.01051.x

M3 - Journal article

VL - 80

SP - 369

EP - 380

JO - European Journal of Haematology. Supplementum

T2 - European Journal of Haematology. Supplementum

JF - European Journal of Haematology. Supplementum

SN - 0902-4506

IS - 5

ER -

ID: 19370538